BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xi SY, Minuk GY. Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World J Hepatol 2018; 10(11): 799-806 [PMID: 30533181 DOI: 10.4254/wjh.v10.i11.799]
URL: https://www.wjgnet.com/1948-5182/full/v10/i11/799.htm
Number Citing Articles
1
Yongjie Niu, Liang Shan, Han Gao, Congcong Zhang, Zijun Qian, Zhixian Wang, Xin Xu, Xiao Zhang, Jiayi Wang, Lifang Ma, Liyun Chen, Yongchun Yu. <p>Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins</p>OncoTargets and Therapy 2020; : 12015 doi: 10.2147/OTT.S279723
2
Xiaobin Zao, Xu Cao, Yijun Liang, Jiaxin Zhang, Hening Chen, Ningyi Zhang, Ruijia Liu, Qian Jin, Yue Chen, Xiaoke Li, Hongbo Du, Guang Chen, Li Hou, Yong'an Ye. The Chinese herbal KangXianYiAi formula inhibits hepatocellular carcinoma by reducing glutathione and inducing ferroptosisPharmacological Research - Modern Chinese Medicine 2023; 8: 100276 doi: 10.1016/j.prmcm.2023.100276
3
Zhulin Wu, Li He, Lianan Wang, Lisheng Peng, Jamal A. Mahajna. Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational StudyEvidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/2396569
4
Fuu-Jen Tsai, Xiang Liu, Chao-Jung Chen, Te-Mao Li, Jian-Shiun Chiou, Po-Heng Chuang, Cheng-Hang Ko, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Wen-Miin Liang, Ying-Ju Lin. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in TaiwanComplementary Therapies in Medicine 2019; 47: 102213 doi: 10.1016/j.ctim.2019.102213
5
Sidra Khan, Alanah Varricchio, Carmela Ricciardelli, Andrea J. Yool. Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant dosesFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1015708
6
Chuihua Sun, Fang Dong, Ting Xiao, Wenni Gao. Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysisPharmaceutical Biology 2021; 59(1): 470 doi: 10.1080/13880209.2021.1915340
7
Wei‐Shu Wang, Yu‐Shan Chen, Chen‐Yu Kuo, Jai‐Jen Tsai, Fei‐Ting Hsu, Jing‐Gung Chung, Po‐Jung Pan. DNA damage and NF‐κB inactivation implicate glycyrrhizic acid‐induced G 1 phase arrest in hepatocellular carcinoma cells Journal of Food Biochemistry 2022; 46(7) doi: 10.1111/jfbc.14128
8
Yinjie Fan, Hang Xue, Huachuan Zheng. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and OutlookJournal of Hepatocellular Carcinoma 2022; : 233 doi: 10.2147/JHC.S358082
9
Yuan Cai, Qing Du, Tian-Hao Deng, Bing-Bing Shen, Yan-Mei Peng, Pu-Hua Zeng, Song-Ren Yu, Yu CAI. Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial PathwayEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/9922059
10
Nur Shahirah Shaharudin, Gurmeet Kaur Surindar Singh, Teh Kek, Sadia Sultan. Targeting signaling pathways with andrographolide in cancer therapy (Review)Molecular and Clinical Oncology 2024; 21(5) doi: 10.3892/mco.2024.2779
11
Yuyao Li, Yue Li, Jinghao Zhang, Longshan Ji, Man Li, Xuehua Sun, Hai Feng, Zhuo Yu, Yueqiu Gao. Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 41 doi: 10.2147/JHC.S346047
12
Xiaonan Chen, Yanan Zhao, Ailin Yang, Yingying Tian, Daoran Pang, Jing Sun, Leimengyuan Tang, Huiming Huang, Ying Wang, Yunfang Zhao, Pengfei Tu, Zhongdong Hu, Jun Li. Chinese Dragon’s Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00669
13
Pan‐pan Feng, You‐kun Qi, Na Li, Hong‐rong Fei. Scutebarbatine A induces cytotoxicity in hepatocellular carcinoma via activation of the MAPK and ER stress signaling pathwaysJournal of Biochemical and Molecular Toxicology 2021; 35(5) doi: 10.1002/jbt.22731
14
Chao Liu, Renwei Huang, Han Yu, Yanju Gong, Peijie Wu, Quansheng Feng, Xia Li. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networksPhytomedicine 2022; 103: 154226 doi: 10.1016/j.phymed.2022.154226
15
Yuting Hu, Wei Qiu, Zhijun Kong, Siyuan Wu, Yi Liu, Chunfu Zhu, Xihu Qin, Aaron Bell. LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR-597/FOSL2 Axis in Hepatocellular CarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/3445970
16
Pei-Li Zhu, Jun-Kui Li, Xiao-Li Jiang, Shi-Qing Zhang, Zhu Zhang, Ying Wang, Zhang Zhang, Wen-Qing Chen, Ken-Kin-Lam Yung. A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cellsJournal of Ethnopharmacology 2023; 312: 116548 doi: 10.1016/j.jep.2023.116548
17
Simo Cheng, Hetong Zhao, Yongbin Meng, Yuyu Guo, Man Yao, Xiaowan Xu, Xiaofeng Zhai, Changquan Ling. Impact of treatment-duration-ratio of traditional Chinese medicine on survival period of primary liver cancer —A real-world studyHeliyon 2022; 8(12): e12358 doi: 10.1016/j.heliyon.2022.e12358
18
Chao Wang, Lili Yang, Shaoheng Xu, Hui Guo, Hewen Guan, Qiannan Wang, Xueyan Jiang, Mingyang Fei, Jinbao Zhang. Systematic analysis of the role and significance of target genes of active ingredients of traditional Chinese medicine injections in the progression and immune microenvironment of hepatocellular carcinomaFrontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1095965
19
Teng Yong-Jiea, Liu Zhuob, Liao Liuc, Chen Yuanc, Huang Xiao-Did, Tian Xue-Feic. STAT3 Inhibition by Centipede Scolopendra Extract in Liver Cancer HepG2 Cells and Orthotopic Mouse Models of Hepatocellular CarcinomaDigital Chinese Medicine 2020; 3(2): 67 doi: 10.1016/j.dcmed.2020.06.002
20
Caiyun Zhang, Hongjiao Xiang, Junmin Wang, Gaoxuan Shao, Peilun Ding, Ying Gao, Hanchen Xu, Guang Ji, Tao Wu. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacologyJournal of Ethnopharmacology 2023; 317: 116676 doi: 10.1016/j.jep.2023.116676
21
Zhijun Li, Haiying Bao. Comparative transcriptome and proteome analysis explores the antitumor key regulators of ergosterone in H22 tumor-bearing miceEuropean Journal of Pharmacology 2023; 953: 175831 doi: 10.1016/j.ejphar.2023.175831
22
Ruiyuan Jiang, Shujuan Luo, Meng Zhang, Wei Wang, Shaoyuan Zhuo, Yajing Wu, Qingmei Qiu, Yuan Yuan, Xiao Jiang. Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signalingMolecular Genetics and Genomics 2023; 298(6): 1479 doi: 10.1007/s00438-023-02070-w
23
Xia Liao, Yang Bu, Qingan Jia. Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and futureGenes & Diseases 2020; 7(3): 370 doi: 10.1016/j.gendis.2019.10.016
24
He-tong Zhao, Yong-bin Meng, Xiao-feng Zhai, Bin-bin Cheng, Sha-sha Yu, Man Yao, Hui-xia Yin, Xu-ying Wan, Yun-ke Yang, Hui Liu, Feng Shen, Chang-quan Ling. Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort studyJournal of Integrative Medicine 2020; 18(4): 319 doi: 10.1016/j.joim.2020.05.003
25
Sa Guo, Nan Xing, Qinyun Du, Bin Luo, Shaohui Wang. Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicineFrontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1325992
26
Xu Cao, Hening Chen, Zhiguo Li, Xiaoke Li, Xianzhao Yang, Qiushuo Jin, Yijun Liang, Jiaxin Zhang, Meiyue Zhou, Ningyi Zhang, Guang Chen, Hongbo Du, Xiaobin Zao, Yong’an Ye. Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinomaFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.985084
27
Jia Yan, Xiu ling Deng, Shi qi Ma, Yu hui Li, Yu min Gao, Gui tao Shi, Hai sheng Wang. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune responseBMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03975-0
28
Yun-yun Zhang, Pan-pan Feng, Hong-fei Wang, Heng Zhang, Tao Liang, Xiao-shan Hao, Feng-ze Wang, Hong-rong Fei. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cellsChemico-Biological Interactions 2022; 365: 110076 doi: 10.1016/j.cbi.2022.110076
29
Dong-hai Zheng, Jia-mei Yang, Jian-xiong Wu, Shu-qun Cheng, Shao-geng Zhang, Dong Wu, Ai-jun Li, Xiao-hui Fu, Xun Li, Fu-chen Qi, Wei-hong Duan, Jun-hui Chen, Zhi-ying Yang, Lu Liang, Jin-xiong Zeng, Wei-da Zheng, Meng-chao Wu. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled TrialChinese Journal of Integrative Medicine 2023; 29(1): 3 doi: 10.1007/s11655-022-3537-4
30
Yuren Zhang, Hetong Zhao, Yuyu Guo, Yongbin Meng, Shasha Yu, Bo Pan, Xiaofeng Zhai. Relationship between thick or greasy tongue-coating microbiota and tongue diagnosis in patients with primary liver cancerFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.903616
31
Chun Li, Xin-You Pan, Mingyun Ma, Jun Zhao, Fengda Zhao, Ya-Ping Lv. Astragalus polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages Pharmaceutical Biology 2021; 59(1): 1531 doi: 10.1080/13880209.2021.1991384
32
Cao Ngoc Minh Trang, Ho Nguyen Quynh Chi, Nguyen Khac Manh, Hoang Nghia Son, Dai-Nghiep Ngo, Le Thanh Long. The Chloroform Extracts of Vietnamese Sophora flavescens Ait. Inhibit the Proliferation of HepG2 Cells through Apoptosis InductionApplied Sciences 2022; 12(12): 5906 doi: 10.3390/app12125906
33
Zahra Farzaneh, Maryam Farzaneh. Herbal Medicine-derived Compounds for the Prevention and Treatment of Hepatocellular CarcinomaCurrent Cancer Therapy Reviews 2022; 18(4): 230 doi: 10.2174/1573394718666220519115626
34
Christian Bailly. Atractylenolides, essential components of Atractylodes-based traditional herbal medicines: Antioxidant, anti-inflammatory and anticancer propertiesEuropean Journal of Pharmacology 2021; 891: 173735 doi: 10.1016/j.ejphar.2020.173735
35
Anping Song, Tingting Ding, Na Wei, Jieren Yang, Mingyue Ma, Shuguo Zheng, Huanhuan Jin. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunityToxicology and Applied Pharmacology 2023; 472: 116574 doi: 10.1016/j.taap.2023.116574
36
Yuan Zhou, Ruifeng Xue, Jinglin Wang, Haozhen Ren. Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transitionBrazilian Journal of Medical and Biological Research 2020; 53(4) doi: 10.1590/1414-431x20198882
37
Dou Dou, Ze-yu Zhang, Zhi-yuan Wu, Xu-dong Qiu, Xiang-gen Zhong, Adolfo Andrade-Cetto. Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta‐AnalysisEvidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/5497041
38
Zhijun Li, Haiying Bao. Anti-tumor effect of Inonotus hispidus petroleum ether extract in H22 tumor-bearing mice and analysis its mechanism by untargeted metabonomicJournal of Ethnopharmacology 2022; 285: 114898 doi: 10.1016/j.jep.2021.114898
39
Jianqing Yu, George G. Chen, Paul B. S. Lai. Targeting hepatocyte growth factor/c‐mesenchymal–epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategiesMedicinal Research Reviews 2021; 41(1): 507 doi: 10.1002/med.21738